Industry / Ukraine
Suspicions Of Collusion As Pharmaceutical Prices Soar
October 2008 | Industry NewsThe cost of pharmaceuticals is causing widespread controversy in Ukraine after retail prices surged by up to 70% during mid-October 2008. The medicines concerned are mostly imported products, which hold a market share of over 75%. Importers have attributed the rises to strengthening of the US dollar; however, the state medicines agency has not excluded the possibility of conspiracy between traders. Prime Minister Yulia Timoshenko said the operation was a planned campaign aimed at destabilising the tense political situation in Ukraine. Timoshenko promised to name the parties and politicians responsible if the situation was not resolved. The drug pricing committee,
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
